Increased oxidative stress in patients with essential thrombocythemia

Area of Science:

• Hematology
• Biochemistry
• Pathophysiology

Background:

• Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by thrombotic and hemorrhagic complications.
• Oxidative stress is implicated in the pathogenesis of various diseases, but its role in ET requires further elucidation.

Purpose of the Study:

• To compare oxidative stress parameters between ET patients and healthy controls.
• To investigate the relationship between oxidative status and vascular events in ET patients.

Main Methods:

• Serum levels of total oxidative status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and malondialdehyde (MDA) were measured in 43 ET patients and 20 healthy volunteers.
• Oxidative status parameters were assessed at diagnosis and 6-month follow-up, and compared between ET patients with and without a history of vascular events.

Main Results:

• ET patients showed significantly higher TOS, OSI, and MDA levels, and lower TAS compared to controls.
• TOS was significantly elevated in ET patients with a history of vascular events.
• OSI and MDA levels decreased significantly after therapy in ET patients.

Conclusions:

• ET is associated with increased oxidative stress and diminished antioxidant capacity.
• Elevated oxidative stress, particularly TOS, is linked to vascular events in ET patients.
• Therapeutic interventions may help reduce oxidative stress markers in ET.